| Code | 90417 | ||||||||||
| MA number | 61/0018/97-S | ||||||||||
| Product Form: | gto por 1x30 ml/225 mg (fľ.skl.hnedá) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Teva B.V., Netherland | ||||||||||
| Therapeutic Class: | 61 - LAXANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | brown glass dropper bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.01.1997 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_LAXYGAL_gto por_12_2024.pdf
|
| SPC: |
SPC_LAXYGAL_gto por_12_2024.pdf
|
| Safety feature | No |
| Data update: | 24.01.2019 |
